Skip to main content
exlitem
Mark Goldin
Back to search
Mark Goldin, Thrombosis expert witness

Mark Goldin

Mark Goldin, M.D. is an expert witness based in great neck, New York. Mark Goldin specializes in Thrombosis, Deep vein thrombosis, Pulmonary embolism. Mark Goldin has testified 1 time and been deposed 6 times.

M.D. ·

great neck, New York

About

Dr. Goldin is an experienced hospitalist and nationally recognized expert in thrombosis and anticoagulation. He is certified by the American Board of Internal Medicine and is a member of the Society of Hospital Medicine, where he holds the designation of Senior Fellow. He is also a Fellow of the American College of Physicians, underscoring his commitment to excellence in the field of internal medicine.

With over 13 years of experience as an attending physician at Long Island Jewish Medical Center, Dr. Goldin has honed his clinical skills in care of medical inpatients as well as surgical co-management. His expertise is widely recognized, and he has been invited to present at numerous regional, national, and international conferences and esteemed institutions, including McMaster University (Hamilton, ON, CA), the University of California, San Diego, and Università degli Studi dell'Insubria (Varese, Italy).

Dr. Goldin's scholarly contributions are equally impressive, with over 35 peer-reviewed publications in high-impact journals, including JAMA Internal Medicine and Circulation. He has served as an ad hoc reviewer for prestigious journals such as the JAMA and Journal of the American College of Cardiology. Additionally, Dr. Goldin has been involved in numerous clinical trials, further solidifying his reputation as a leading expert in his field.

With his extensive knowledge, clinical experience, and academic achievements, Dr. Mark Goldin is a highly credible and reliable expert witness in cases involving thrombosis, anticoagulation, and hospital medicine. His professionalism, attention to detail, and commitment to excellence make him an invaluable asset in legal proceedings requiring expert testimony.

Specialties

Thrombosis
Deep vein thrombosis
Pulmonary embolism
Anticoagulation
Surgical Co-management
Internal Medicine
Medical Informatics
Medical Malpractice
Health System Policy
Research
View all (20)
Electronic Health Record
Electronic Medical Record
Quality & Safety
Medical Education
Process Improvement
Venous thromboembolism
COVID-19 thromboprophylaxis
Reversal of critical bleeding in anticoagulated patients
Clinical decision support tools for thromboprophylaxis
Clinical trials
75
Engagements

Common Questions

What does Mark Goldin testify about?
Mark Goldin testifies about Thrombosis, Deep vein thrombosis, and Pulmonary embolism.
Where is Mark Goldin based?
Mark Goldin is based in great neck, New York.
Has Mark Goldin testified or been deposed?
Mark Goldin has testified 1 time and been deposed 6 times.

Work Experience

Professor of MedicineCurrent
Zucker School of Medicine at Hofstra/Northwell, Northwell Health
Adjunct Clinical Assistant Professor of MedicineCurrent
Albert Einstein College of Medicine
Attending Physician, Hospital MedicineCurrent
Northwell Health

Education

  • MD in Internal Medicine
    Albert Einstein College of Medicine
    –
  • AB, cum laude in Biology with Honors
    Harvard University
    –
  • Residency in Internal Medicine
    University of California, San Diego
    –

    Program Director: Elaine Muchmore

  • Physician Executive Leadership Development Program
    Northwell Health
    –
  • Mathematics of Machine Learning
    Deeplearning.ai (Coursera)
    –
  • Change Management
    Northwell Health
    –
  • Hospital Medicine Leadership Development Program
    Northwell Health
    –
  • Improvement Science Methodology
    Northwell Health
    –
  • Academic Hospitalist Academy
    Society of Hospital Medicine
    –

Credentials & Licenses

  • Other
    American Board of Internal MedicineSelf-reported
  • Other
    New York State Medical BoardSelf-reported
  • Other
    MD

    Albert Einstein College of Medicine

    Self-reported
  • Other
    AB, cum laude

    Harvard University

    Self-reported

Testimony

1
Times Testified
6
Times Deposed
100% plaintiff · 0% defense
Plaintiff / Defense

Publications

Clinical decision support tools to enhance thromboprophylaxis in order COVID-19 patients.
Society of Hospital Medicine
Reversal of Direct Oral Anticoagulants (DOACs) for Critical Bleeding or Urgent Procedures.
Journal of Clinical Medicine
Universal clinical decision support tool for thromboprophylaxis in hospitalized COVID-19 patients: post-hoc analysis of the IMPROVE-DD cluster randomized trial.
Journal of Thrombosis and Haemostasis
Clinical pathways and outcomes of andexanet alfa administration for reversal of critical bleeding in patients on oral direct factor Xa inhibitors.
TH Open
Universal EHRs Clinical Decision Support for Thromboprophylaxis in Medical Inpatients: A Cluster Randomized Trial.
JACC Advances
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial.
Circulation
Rivaroxaban plus aspirin for extended thromboprophylaxis in acutely ill medical patients: insights from the MARINER trial.
TH Open
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
JAMA Internal Medicine
Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older.
Journal of Thrombosis and Haemostasis
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry.
Blood
Thromboembolism Risk Profiles in Non-Valvular Atrial Fibrillation: How Can Machine Learning-Based Analysis Add to Our Understanding?
Journal of General Internal Medicine
Implementation of Hip Fracture Co-Management Program (AGS CoCare: Ortho®) in a Large Health System.
Journal of the American Geriatric Society
Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH.
Journal of Thrombosis and Haemostasis
Warfarin to direct or anticoagulants (DOACs) transition in eligible patients: a quality improvement initiative at a quaternary academic medical center.
Society of Hospital Medicine
Implementation of a Geriatrics-Focused Orthopaedic and Hospitalist Fracture Program Decreases Perioperative Complications and Improves Resource Utilization.
Journal of Orthopaedic Trauma

Professional Memberships

  • Society of Hospital Medicine
    Professional society· Senior Fellow
    Current
  • American College of Physicians
    Professional society· Fellow
    Current

Related Experts